Small Hospitals
Market Cap
₹2,419 ₹2,419 Cr.
P/E
43.36
PEG
2.74
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

The thesis comes alive if occupied bed days and blended ARPOB continue improving, with the Mother & Child Care mix and EBITDA margin serving as key watchpoints.

The bull path requires stronger volume, realization and service mix, while the bear path is driven by weaker occupancy, lower ARPOB, mix deterioration or margin pressure.

Key Ratios

Debt to Equity
Debt to Equity
0.50
Div Yield (%)
Div Yield (%)
-
Individual < 2 lac
Individual < 2 lac
13.27 %
Institutions
Institutions
0.02 %
Market cap
Market cap
2,419 Cr
No. of Shareholders
No. of Shareholders
88,487
OPM (%)
OPM (%)
30.20 %
PE
PE
43.36
Prom Holding
Prom Holding
75.00 %
ROCE (%)
ROCE (%)
14.02
ROE (%)
ROE (%)
13.04
Sales
Sales
330 Cr
  • KMC Speciality Hosp.
  • Dr Agarwals Eye Hosp
  • Shalby
Last updated on 15 Sep 2026
  • KMC Speciality Hospitals runs a single-site multi-specialty hospital in Trichy with 330 census beds of 450 built.
  • It earns mostly from cash payors at ~69%, with 24% from TPA and corporates and 8% from government schemes.
  • It opened the 200-bed Maa Kauvery women and child block in Jan 2024. That block shifted its focus to mother and child care.
  • Mother and child brings ~26% of revenue. Neuro brings ~20%.
  • It is building about 500 Trichy beds for ₹486Cr and a 91-bed leased Bengaluru unit for ₹33Cr. Per management, Trichy focuses on centres of excellence.
  • It holds ₹81.2Cr cash against ₹68.3Cr borrowings. The approved build will still need internal accruals and term debt.
  • It is mid-ramp on recent capacity and early in a large build. Near-term profit depends on holding occupancy and bed rates with ~30% margins.
  • It still earns from a single Trichy site. Its parent has pledged part of its holding for debt, though KMC Speciality Hospitals shares are unencumbered.
  • Maa Kauvery ramp ongoing
    occupancy, ARPOB and mix show whether the recent margin recovery holds.
  • Bengaluru Mother and Child unit Q2FY28
    The unit adds ~91 leased beds for ₹33Cr, about 28% of today's 330 beds.
  • Trichy Mother and Child block Q4FY28
    The block adds ~100 beds for ₹64Cr, about 30% of today's 330 beds.
  • Trichy Super-Speciality Block Q2FY30
    The block adds ~400 beds for ₹422Cr including land, about 121% of today's 330 beds.
  • Promoter encumbrance No timeline
    any release or invocation of the parent's 19.90% pledge and 32.40% NDU becomes visible.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
65
52W Range
High
154
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

12 Yes

Positive for this company

2 Neutral

Neutral for this company

3 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Therapeutic Area Break-Up

Operational Metrics

    Select a Metric
    • Average Daily Revenue Per Occupied Bed (Rs)
    • Hospital Occupancy Rate (%)
    • Average Length Of Stay (Days)
    • Operational Beds (.)
    • Number of Outpatient Visits - Quarterly (.)

    Peer Comparison

    FAQs on KMC Speciality Hospitals (India) Ltd. Business

    KMC Speciality Hospital, formerly known as Seahorse Hospital, has expanded significantly over the years with an increase from 30 to 200 beds, 10 to 100 doctors, and over 1000 staff members. The management takeover was completed in February 2008.

    KMC Speciality Hosp. major competitors are Dr Agarwals Eye Hosp, Shalby, Indraprastha Medical, Aashka Hospitals, Fortis MalarHospital, Tejnaksh Healthcare, Global Longlife Hosp.
    Market Cap of KMC Speciality Hosp. is ₹2,150 Crs.
    While the median market cap of its peers are ₹195 Crs.

    KMC Speciality Hosp. seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation Mar Jun Aug Jun Sep Nov Mar Jun Sep Dec Dec
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material